Rigel Pharmaceuticals reported $1.2M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Agenus AGEN:US USD 15.61M 1.88M
Amgen AMGN:US USD 368M 40M
Applied Genetic Technologies AGTC:US USD 657K 6K
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Bristol Myers Squibb BMY:US USD 299M 14M
Eli Lilly And LLY:US USD 81.5M 300K
Halozyme Therapeutics HALO:US USD 7.51M 4.41M
Immunogen IMGN:US USD 867K 211K
Intrexon XON:US USD 2.04M 27K
Karyopharm Therapeutics KPTI:US USD 6.11M 199K
Neurocrine Biosciences NBIX:US USD 1.2M 1000K
Pfizer PFE:US USD 311M 18M
Regeneron Pharmaceuticals REGN:US USD 15.3M 2.2M
Veracyte VCYT:US USD 61K 9K